{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:15:08Z","timestamp":1786677308646,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173054"],"award-info":[{"award-number":["82173054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515020048"],"award-info":[{"award-number":["2022B1515020048"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.breast.2025.104455","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T22:01:41Z","timestamp":1742421701000},"page":"104455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prognostic factors and treatment insights for metastatic malignant phyllode tumors"],"prefix":"10.1016","volume":"81","author":[{"given":"Mengjia","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rurong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8111-6050","authenticated-orcid":false,"given":"Yan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.breast.2025.104455_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/1097-0142(20001001)89:7<1502::AID-CNCR13>3.0.CO;2-P","article-title":"Primary treatment of cystosarcoma phyllodes of the breast","volume":"89","author":"Chaney","year":"2000","journal-title":"Cancer"},{"issue":"909","key":"10.1016\/j.breast.2025.104455_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/pmj.77.909.428","article-title":"Phyllodes tumours","volume":"77","author":"Parker","year":"2001","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.breast.2025.104455_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in Oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.breast.2025.104455_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jso.26820","article-title":"Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast","volume":"125","author":"Gutnik","year":"2022","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2025.104455_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1006260225618","article-title":"Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors","volume":"57","author":"Barth","year":"1999","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.12876","article-title":"Phyllodes tumours of the breast: a consensus review","volume":"68","author":"Tan","year":"2016","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.breast.2025.104455_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/0019-509X.123625","article-title":"Challenges in management of phyllodes tumors of the breast: a retrospective analysis of 150 patients","volume":"50","author":"Ramakant","year":"2013","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.breast.2025.104455_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113423","article-title":"Primary malignant phyllodes tumors of the breast: a retrospective analysis from a referral center","volume":"196","author":"Valenza","year":"2024","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.breast.2025.104455_bib9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1245\/s10434-019-08097-x","article-title":"Impact of metastasis surgery and alkylating-agent-based chemotherapy on outcomes of metastatic malignant phyllodes tumors: a multicenter retrospective study","volume":"27","author":"Neron","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2025.104455_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10549-021-06116-8","article-title":"Outcomes of systemic therapy in metastatic phyllodes tumor of the breast","volume":"186","author":"Parkes","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2025.104455_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1200\/JCO.20.02647","article-title":"Contemporary multi-institutional cohort of 550 cases of phyllodes tumors (2007-2017) demonstrates a need for more individualized margin guidelines","volume":"39","author":"Rosenberger","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.breast.2025.104455_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1524-4741.2007.00510.x","article-title":"Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast","volume":"13","author":"Morales-Vasquez","year":"2007","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12885-019-5585-5","article-title":"Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis","volume":"19","author":"Chao","year":"2019","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.breast.2025.104455_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in Oncology","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","article-title":"Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)","volume":"13","author":"Huang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41523-022-00413-1","article-title":"Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor","volume":"8","author":"Ng","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"10.1016\/j.breast.2025.104455_bib18","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2024.7023","article-title":"The impact of adjuvant chemotherapy on the long-term prognosis of breast malignant phyllodes tumors: a propensity score-matched study","volume":"22","author":"Zhuang","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.breast.2025.104455_bib19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-022-06524-4","article-title":"Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses","volume":"192","author":"Palassini","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.breast.2025.104455_bib20","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/codi.15833","article-title":"The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort","volume":"23","author":"Treasure","year":"2021","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.breast.2025.104455_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.euf.2022.10.013","article-title":"Surgical metastasectomy for visceral and bone prostate cancer metastases: a mini-review","volume":"9","author":"Rajwa","year":"2023","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archsurg.142.1.70","article-title":"Benefit of surgical treatment of lung metastasis in soft tissue sarcoma","volume":"142","author":"Rehders","year":"2007","journal-title":"Arch Surg"},{"key":"10.1016\/j.breast.2025.104455_bib23","first-page":"321","article-title":"Pulmonary metastasectomy for soft tissue sarcomas: is it justified? Recent Results","volume":"179","author":"Pfannschmidt","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.breast.2025.104455_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1055\/s-2006-924248","article-title":"Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients","volume":"54","author":"Pfannschmidt","year":"2006","journal-title":"Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.breast.2025.104455_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/JTO.0b013e3182106f5c","article-title":"Improved survival after pulmonary metastasectomy for soft tissue sarcoma","volume":"6","author":"Predina","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104455_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6605737","article-title":"Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases","volume":"103","author":"Mekenkamp","year":"2010","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.breast.2025.104455_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/SLA.0000000000002564","article-title":"Time of metastasis and outcome in colorectal cancer","volume":"269","author":"Rahbari","year":"2019","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib28","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European society for radiotherapy and Oncology and European organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10185","key":"10.1016\/j.breast.2025.104455_bib29","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2025.104455_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13014-023-02255-y","article-title":"Treatment outcomes of stereotactic body radiation therapy for pulmonary metastasis from sarcoma: a multicenter, retrospective study","volume":"18","author":"Lee","year":"2023","journal-title":"Radiat Oncol"},{"issue":"9","key":"10.1016\/j.breast.2025.104455_bib31","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jtho.2017.05.015","article-title":"Long-term outcome of surgery or stereotactic radiotherapy for lung oligometastases","volume":"12","author":"Lodeweges","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.breast.2025.104455_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113924","article-title":"Real-world data on malignant and borderline phyllodes tumors of the breast: a population-based study of all 921 cases in The Netherlands (1989 -2020)","volume":"201","author":"Bartels","year":"2024","journal-title":"Eur J Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:56Z","timestamp":1778570576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625004722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S0960977625004722"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104455","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and treatment insights for metastatic malignant phyllode tumors","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104455"}}